Feed JNJ
JN

Johnson & Johnson

JNJ · NYSE

$271.21 +0.19% (+$0.53)
1M +1.19%
Market Cap $649.5B
P/E Ratio 30.87x
Div. Yield 1.96%
ROE 25.74%

Bulios Fair Price

$261.11

3.7% downside

Trenutna cena

$271.21

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price se delnica JNJ trenutno trguje blizu svoje poštene vrednosti. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Analiza

AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.

Piotroski F-Score Strong
8/9
Valuation
33 /100
Expensive
P/E 30.87x
EV/EBITDA 20.10x
P/S 6.63x
Growth
57 /100
Stable
EPS growth 17.90%
Rev. growth 5.60%
FCF growth 4.65%
Profitability
100 /100
Strong
Gross margin 70.45%
Net margin 21.48%
Op. margin 26.81%
Quality
79 /100
Excellent
ROIC 13.89%
ROE 25.74%
ROA 10.46%
Debt
81 /100
Low
Debt/Equity 0.58x
Current ratio 1.09x
Int. coverage 25.67x
Stability
47 /100
Moderate
Beta 0.24x
Rev. volatility 1.15%
EPS volatility 89.73%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o JNJ
Online

O podjetju

Johnson & Johnson (JNJ) is a global pharmaceutical, medical, and consumer goods manufacturing company with a diverse portfolio of products. For over 130 years, they have been delivering innovative medicines, medical devices, and consumer products that improve people's lives worldwide. With a strong market position and a history of consistent dividend growth, Johnson & Johnson stock is attractive to conservative investors seeking stable and income-generating returns. Add JNJ stock to your watchlist on Bulios and stay informed about the latest news and innovations from this established company.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Joaquin Duato

Employees

141,700

Headquarters

New Brunswick

Prihajajoči dogodki

13 OKT.

Earnings

Upcoming earnings report

15d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.